p-ARDS n = 31 | ep-ARDS n = 8 | p value | |
---|---|---|---|
Time after discharge (year) | 1.06 (1–1.11) | 1.05 (0.94–1.11) | 0.75 |
Respiratory symptoms at rest, exercise, maintenance treatment | 23 (74.2%) | 1 (12.5%) | 0.0026 |
Chronic cough | 5 (16.1%) | 0 | 0.56 |
Wheezing episodes | 16 (51.6%) | 0 | 0.012 |
A least 3 wheezing episodes | 10 (32.3%) | 0 | NA |
Lower respiratory tract infection | 11 (35.5%) | 0 | 0.078 |
A least 3 episodes | 3 (9.7%) | 0 | NA |
Maintenance respiratory treatment | 19 (63.3%) | 0 | 0.003 |
Inhaled glucocorticosteroids | 16 (51.6%) | 0 | 0.012 |
Inhaled long-acting β2-agonists | 7 (22.6%) | 0 | 0.31 |
Inhaled rapid-acting β2-agonists | 14 (45.2%) | 0 | 0.034 |
Inhaled rapid-acting atropinic | 1 (3.2%) | 0 | NA |
Leukotriene modifier | 2 (6.5%) | 0 | NA |
Oxygen therapy | 1 (3.2%) | 0 | NA |
Course of systemic glucocorticosteroids in the year | 4 (12.9%) | 0 | NA |
Antibiotics | 9 (29.0%) | 0 | 0.16 |